NanoVibronix, Inc. (NASDAQ:NAOV) Sees Significant Increase in Short Interest

NanoVibronix, Inc. (NASDAQ:NAOV) was the target of a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 82,500 shares, an increase of 113.2% from the March 15th total of 38,700 shares. Based on an average trading volume of 2,430,000 shares, the days-to-cover ratio is presently 0.0 days. Currently, 13.0% of the shares of the company are sold short.

NanoVibronix Stock Down 2.5 %

NASDAQ NAOV opened at $7.16 on Friday. The firm has a 50-day moving average price of $4.44 and a two-hundred day moving average price of $5.72. NanoVibronix has a 12-month low of $1.92 and a 12-month high of $16.25. The company has a market capitalization of $5.43 million, a P/E ratio of -5.82 and a beta of 1.84.

NanoVibronix Company Profile

NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.